Sumatriptan and Nyquil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan (sumatriptan succinate) and Nyquil (acetaminophen / dextromethorphan / doxylamine / pseudoephedrine). Common drug interactions include gastrooesophageal reflux disease among females and craniosynostosis among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan and Nyquil. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan?

Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.

What is Nyquil?

Nyquil has active ingredients of acetaminophen / dextromethorphan / doxylamine / pseudoephedrine. It is often used in cold symptoms. eHealthMe is studying from 2,240 Nyquil users. Check the latest studies of Nyquil.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

18 people who take Sumatriptan and Nyquil together, and have interactions are studied.

Sumatriptan and Nyquil drug interactions.

What are the common drug interactions of Sumatriptan and Nyquil, by gender? *:

female:

  1. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  2. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  3. Therapeutic response unexpected
  4. Alopecia (absence of hair from areas of the body)
  5. Inflammation
  6. Sedation
  7. Asthenia (weakness)
  8. Loss of consciousness
  9. Blood pressure fluctuation
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

male:

  1. Craniosynostosis (a baby is born with an abnormally shaped skull or develops one during growth)
  2. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  3. Infection
  4. Nephrolithiasis (calculi in the kidneys)
  5. Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
  6. Premature baby

What are the common drug interactions of Sumatriptan and Nyquil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Alopecia (absence of hair from areas of the body)
  2. Inflammation
  3. Sinusitis (inflammation of sinus)
  4. Sedation
  5. Blood pressure fluctuation
  6. Blood pressure increased
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Dyskinesia (abnormality or impairment of voluntary movement)
  9. Loss of consciousness
  10. Rib fracture

60+:

  1. Bipolar disorder (mood disorder)
  2. Blood pressure increased
  3. Blood folate decreased
  4. Cerebral disorder (brain disease)
  5. Confusional state
  6. Dyspepsia (indigestion)
  7. Ear infection
  8. Escherichia infection (bacterial infection by escherichia coli)
  9. Fall
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 66.67%
  2. Pain: 4 people, 22.22%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 16.67%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.11%
  6. Drowsiness: 2 people, 11.11%
  7. Stress And Anxiety: 1 person, 5.56%
  8. Back Pain: 1 person, 5.56%
  9. Balance Disorder: 1 person, 5.56%
  10. Bipolar Disorder (mood disorder): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan and Nyquil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumatriptan and Nyquil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nyquil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nyquil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and acetaminophen / dextromethorphan / doxylamine / pseudoephedrine (the active ingredients of Sumatriptan and Nyquil, respectively), and Sumatriptan and Nyquil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: